Nearly 1 out of 3 adults in the Gulf region has Obesity1 today. Overweight and obesity rates have nearly tripled in the GCC countries over the past four decades², a trend that threatens healthcare systems, economies, and individual lives³.
At Novo Nordisk, we are committed to tackle and solve this current local health challenge by bringing healthcare solutions which can address the needs of people living with obesity.
We are inviting all start-ups developing digitally integrated health ecosystems, striving towards a seamless patient experience and journey, to submit their proposals on this website.
1. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO
2. AlAbdulKader, A.M., Tuwairqi, K. & Rao, G. Obesity and Cardiovascular Risk in the Arab Gulf States. Curr Cardiovasc Risk Rep 14, 7 (2020). https://doi.org/10.1007/s12170-020-00642-8
3. AlNohair et al, Int J Health Sci (Qassim). 2014 Jan; 8(1): 79–83
NovoNordisk will provide non-equity funding to a start-up or scale-up depending upon the scope of work and required resources to deliver a seamless patient experience.
The selected start-up will be working closely with Novo Nordisk, a multinational pharma company leader in Obesity management. You will work closely with medical, marketing & digital teams, both locally & regionally, during the project implementation.
Opportunity to get more exposure to the Novo Nordisk network, and investors through our partner Plug and Play.